Literature DB >> 6813127

Morphine glucuronidation in human fetal and adult liver.

G M Pacifici, J Säwe, L Kager, A Rane.   

Abstract

The glucuronyltransferase activity towards morphine was measured in microsomes isolated from liver specimens obtained from human fetuses and cancer patients. All the fetal livers investigated had measurable UDP-glucuronyltransferase activity towards morphine. There was no correlation between the gestational age (15 to 27 weeks) and the glucuronidation rate. The mean value of the enzymatic activities was higher in fetal livers obtained by hysterotomy (0.20 nmoles x min-1 x mg-1) than in livers obtained after induced abortion (0.11 nmoles x min-1 x mg-1). The average rate of glucuronidation in microsomes from adult liver (mean 1.15 nmoles x min-1 x mg-1) was 6 to 10 times higher than in the fetal liver microsomes. Together with previous investigations on human adult and fetal liver glucuronidation, the present results support the theory of heterogeneity of human UDP-glucuronyltransferase.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6813127     DOI: 10.1007/bf00609630

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  17 in total

1.  Pharmacokinetics of acetaminophen in the human neonate: formation of acetaminophen glucuronide and sulfate in relation to plasma bilirubin concentration and D-glucaric acid excretion.

Authors:  G Levy; N N Khanna; D M Soda; O Tsuzuki; L Stern
Journal:  Pediatrics       Date:  1975-06       Impact factor: 7.124

2.  Drugs and fetal metabolism.

Authors:  A Rane; F Sjöqvist; S Orrenius
Journal:  Clin Pharmacol Ther       Date:  1973 Jul-Aug       Impact factor: 6.875

3.  Placental passage of oxazepam and its metabolism in mother and newborn.

Authors:  G Tomson; N O Lunell; A Sundwall; A Rane
Journal:  Clin Pharmacol Ther       Date:  1979-01       Impact factor: 6.875

4.  Separation and partial purification of two differentially inducible UDP-glucuronyltransferases from rat liver.

Authors:  K W Bock; U C von Clausbruch; D Josting; H Ottenwälder
Journal:  Biochem Pharmacol       Date:  1977-06-01       Impact factor: 5.858

5.  Acetaminophen: potentially toxic metabolite formed by human fetal and adult liver microsomes and isolated fetal liver cells.

Authors:  D E Rollins; C von Bahr; H Glaumann; P Moldéus; A Rane
Journal:  Science       Date:  1979-09-28       Impact factor: 47.728

6.  Morphine metabolism. V. Isolation of separate glucuronyltransferase activities for morphine and p-nitrophenol from rabbit liver microsomes.

Authors:  E D Villar; E Sanchez; T R Tephly
Journal:  Drug Metab Dispos       Date:  1977 May-Jun       Impact factor: 3.922

7.  Determination of microsomal UDP-glucuronyltransferase in needle-biopsy specimens of human liver.

Authors:  K W Bock; G Brunner; H Hoensch; E Huber; D Josting
Journal:  Eur J Clin Pharmacol       Date:  1978-12-18       Impact factor: 2.953

8.  Postnatal development of uridine diphosphate glucuronyltransferase activity towards bilirubin and 2-aminophenol in human liver.

Authors:  S Onishi; N Kawade; S Itoh; K Isobe; S Sugiyama
Journal:  Biochem J       Date:  1979-12-15       Impact factor: 3.857

9.  Inhibition of morphine glucuronidation by oxazepam in human fetal liver microsomes.

Authors:  G M Pacifici; A Rane
Journal:  Drug Metab Dispos       Date:  1981 Nov-Dec       Impact factor: 3.922

10.  Sulphate and glucuronic acid conjugation of harmol in human fetal and adult liver tissue.

Authors:  E Steiner; C von Bahr; A Rane
Journal:  Dev Pharmacol Ther       Date:  1982
View more
  34 in total

Review 1.  Glucuronidation in humans. Pharmacogenetic and developmental aspects.

Authors:  S N de Wildt; G L Kearns; J S Leeder; J N van den Anker
Journal:  Clin Pharmacokinet       Date:  1999-06       Impact factor: 6.447

2.  Uridine 5'-diphosphoglucuronic acid (UDPGLcUA) in the human fetal liver, kidney and placenta.

Authors:  M Cappiello; L Giuliani; A Rane; G M Pacifici
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2000 Jul-Dec       Impact factor: 2.441

Review 3.  Strong opioids in pediatric palliative medicine.

Authors:  Richard D W Hain; Angela Miser; Mary Devins; W Hamish B Wallace
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

Review 4.  Population clinical pharmacology of children: modelling covariate effects.

Authors:  Brian J Anderson; Karel Allegaert; Nicholas H G Holford
Journal:  Eur J Pediatr       Date:  2006-06-29       Impact factor: 3.183

5.  Genetic variation, expression and ontogeny of sulfotransferase SULT2A1 in humans.

Authors:  L Ekström; A Rane
Journal:  Pharmacogenomics J       Date:  2015-03-24       Impact factor: 3.550

6.  A mechanistic approach for the scaling of clearance in children.

Authors:  Andrea N Edginton; Walter Schmitt; Barbara Voith; Stefan Willmann
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

Review 7.  Pain relief.

Authors:  I A Choonara
Journal:  Arch Dis Child       Date:  1989-08       Impact factor: 3.791

8.  Sulphation and glucuronidation of ritodrine in human foetal and adult tissues.

Authors:  G M Pacifici; M Kubrich; L Giuliani; M de Vries; A Rane
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

Review 9.  Ontogeny of hepatic and renal systemic clearance pathways in infants: part I.

Authors:  Jane Alcorn; Patrick J McNamara
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

10.  N-demethylation of ethylmorphine in pregnant and non-pregnant women and in men: an evaluation of the effects of sex steroids.

Authors:  E Gerdin; A Rane
Journal:  Br J Clin Pharmacol       Date:  1992-09       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.